Sun Pharmaceutical Industries receives four observations from USFDA for its Halol facility

22 Jun 2019 Evaluate

Sun Pharmaceutical Industries has received four observations from United States Food and Drug Administration (USFDA) for its Halol facility in Gujarat. The company will submit its response on the observations to the USFDA within 15 business days. The company is committed to addressing these observations promptly.

The United States Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAl) of company's Halol facility from June 3 to June 11, 2019.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1729.95 -31.50 (-1.79%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×